Presentation TCT 2024 Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials Presenter: Lei Song October 30, 2024
Presentation TCT 2024 TCT 506: Comparison of Healing Pattern Using Optical Coherence Tomography in Small vs Large Coronary Arteries After Sirolimus-eluting Stents Implantation Presenter: Atul Abhyankar October 30, 2024
Presentation TCT 2024 TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study Presenter: Atul Abhyankar October 30, 2024
Presentation TCT 2024 TCT 504: Comparison of Vessel Responses Following Combined Sirolimus-Eluting and Endothelial Progenitor Cell Stent and Ultra-Thin Sirolimus-Eluting Stent Implantation by Serial OCT and Coronary Angioscopy Presenter: Atsushi Kikuchi October 30, 2024
Presentation TCT 2024 3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial Presenter: Hongbo Yang October 30, 2024
Presentation TCT 2024 TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Presenter: Bernardo Cortese October 29, 2024
Presentation TCT 2024 TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials Presenter: Paulo Caramori October 29, 2024
Presentation TCT 2024 TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry Presenter: Aayush Singal October 29, 2024
Presentation TCT 2024 TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry Presenter: Shoichi Kuramitsu October 29, 2024
Presentation TCT 2024 TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials Presenter: Lei Song October 29, 2024
Presentation TCT 2024 TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes Presenter: Matthias Lutz October 29, 2024
Presentation TCT 2024 TCT 1292: Recurrent Very Late Stent Thrombosis Due to Multiple Interstruts Hollows After First-Generation Sirolimus-Eluting Stent Implantation Presenter: Takayuki Ishihara October 29, 2024
Presentation TCT 2024 TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures Presenter: Simon Eccleshall October 29, 2024
Presentation TCT 2024 TCT 42: Sirolimus Eluting Balloon for Coronary Intervention: An All-Comers Registry Presenter: Marco Ferrone October 28, 2024
Presentation TCT 2024 TCT 434: Clinical Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) Presenter: Kiril Karamfiloff October 28, 2024
Presentation TCT 2024 TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial Presenter: David Kandzari October 28, 2024
Presentation TCT 2024 A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study Presenter: Tzung-Dau Wang October 28, 2024
Presentation TCT 2024 TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) Presenter: Kiril Karamfiloff October 28, 2024
Presentation TCT 2024 Magnesium-Based Resorbable Scaffold vs Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: Final 5-Year Results of the MAGSTEMI Randomized Controlled Trial Presenter: Manel Sabate October 27, 2024
Presentation TCT 2024 TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds Presenter: Jiasheng Yin October 27, 2024